Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Fishbane

Showing results (201-210 of 234) with videos related to

Pageof 24
Sort By:
Kidney International|July 6, 2025
The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysisSteven Fishbane, Laura M Dember, Michel Jadoul, et al.
Kidney International|March 15, 2013
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studiesSuetonia Palmer, Mariacristina Vecchio, Jonathan C Craig, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 22, 2020
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney InjuryJia H Ng, Jamie S Hirsch, Azzour Hazzan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2025
Characteristics and cardio-renal outcomes in CKD patients receiving guideline-directed therapy: insights from DISCOVER CKDRoberto Pecoits-Filho, Eiichiro Kanda, Naoki Kashihara, et al.
Clinical Nephrology|November 4, 2022
Use of TIMP-2 and IGFBP-7 for prediction of postoperative acute kidney injury after cardiac surgeryPey-Jen Yu, Gabriela Rodriguez, Hugh Cassiere, et al.
Journal of Thrombosis and Thrombolysis|July 13, 2010
Improvement of hemodialysis catheter function with tenecteplase: a phase III, open-label study: TROPICS 4Steven Fishbane, Samuel L Milligan, Kenneth D Lempert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2020
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 studySimon D Roger, Philip T Lavin, Edgar V Lerma, et al.
Journal of the American Society of Nephrology : JASN|April 1, 2022
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES StudySteven Fishbane, Carol A Pollock, Mohamed El-Shahawy, et al.
Kidney International|April 23, 2002
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextranBeckie Michael, Daniel W Coyne, Steven Fishbane, et al.
Kidney360|July 25, 2024
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective CohortSteven Fishbane, Juan-Jesus Carrero, Supriya Kumar, et al.
Pageof 24

Showing results (201-210 of 234) with videos related to

Sort By:
Pageof 24
Kidney International|July 6, 2025
The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysisSteven Fishbane, Laura M Dember, Michel Jadoul, et al.
Kidney International|March 15, 2013
Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studiesSuetonia Palmer, Mariacristina Vecchio, Jonathan C Craig, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 22, 2020
Outcomes Among Patients Hospitalized With COVID-19 and Acute Kidney InjuryJia H Ng, Jamie S Hirsch, Azzour Hazzan, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2025
Characteristics and cardio-renal outcomes in CKD patients receiving guideline-directed therapy: insights from DISCOVER CKDRoberto Pecoits-Filho, Eiichiro Kanda, Naoki Kashihara, et al.
Clinical Nephrology|November 4, 2022
Use of TIMP-2 and IGFBP-7 for prediction of postoperative acute kidney injury after cardiac surgeryPey-Jen Yu, Gabriela Rodriguez, Hugh Cassiere, et al.
Journal of Thrombosis and Thrombolysis|July 13, 2010
Improvement of hemodialysis catheter function with tenecteplase: a phase III, open-label study: TROPICS 4Steven Fishbane, Samuel L Milligan, Kenneth D Lempert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2020
Long-term safety and efficacy of sodium zirconium cyclosilicate for hyperkalaemia in patients with mild/moderate versus severe/end-stage chronic kidney disease: comparative results from an open-label, Phase 3 studySimon D Roger, Philip T Lavin, Edgar V Lerma, et al.
Journal of the American Society of Nephrology : JASN|April 1, 2022
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES StudySteven Fishbane, Carol A Pollock, Mohamed El-Shahawy, et al.
Kidney International|April 23, 2002
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextranBeckie Michael, Daniel W Coyne, Steven Fishbane, et al.
Kidney360|July 25, 2024
Hyperkalemia Burden and Treatment Pathways in Patients with CKD: Findings From the DISCOVER CKD Retrospective CohortSteven Fishbane, Juan-Jesus Carrero, Supriya Kumar, et al.
Pageof 24